RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Osteoclasts and Probiotics Mediate Significant Expansion, Functional Activation and Supercharging in NK, γδ T, and CD3+ T Cells: Use in Cancer Immunotherapy.
Osteoclasts and Probiotics Mediate Significant Expansion, Functional Activation and Supercharging in NK, γδ T, and CD3+ T Cells: Use in Cancer Immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们之前的研究已提出破骨细胞(OCs)是NK细胞的主要激活因子。研究发现,OCs具有诱导细胞扩增的能力,并通过颗粒释放以及增加TNF-α和TRAIL的分泌来提高NK细胞的细胞毒活性,从而分别在短期和长期内导致肿瘤裂解增加。OC诱导扩增的NK细胞因其功能活性显著增高以及细胞扩增率显著更高而被命名为超级充电NK细胞(sNK)。
然而,目前尚不清楚OC对NK细胞的介导效应是否具有特异性,或者其他细胞毒性免疫细胞是否也能被OC扩增和激活。我们选择聚焦于γδ T细胞和pan T细胞,后者也包括CD8+ T细胞。在本文中,我们报道OCs能够扩增并在功能上激活γδ T细胞和pan T细胞。扩增后的γδ T和pan T细胞能够分泌高水平INF-γ,尽管其动力学与NK细胞不同,此外,它们无法杀伤NK特异性靶标。由于我们使用人源化-BLT(hu-BLT)小鼠作为人类疾病模型,我们接下来确定通过OCs实现的NK和T细胞激活在来自hu-BLT小鼠的细胞中是否也同样明显。与人类相似,OCs能够增加来自hu-BLT小鼠的NK或T细胞培养物中的细胞扩增和IFN-γ分泌,这进一步证明这些小鼠是研究人类疾病的合适模型。
因此,这些研究表明,CD3+ T或γδ T细胞可以像NK细胞一样被OCs增殖和超级充电;因此,它们可以单独或联合用于癌症的细胞治疗。
Our previous studies have introduced osteoclasts (OCs) as major activators of NK cells. It was found that OCs exhibit the capabilities of inducing cell expansion as well as increasing the cytotoxic activity of NK cells by granule release and increasing the secretion of TNF-α and TRAIL, leading to increased lysis of tumors in short-term as well as long-term periods, respectively.
OC- induced expanded NK cells were named supercharged NK cells (sNK) due to their significantly high functional activity as well as their significantly higher cell expansion rate. It is, however, unclear whether the OC-mediated effect in NK cells is specific or whether other cytotoxic immune cells can also be expanded and activated by OCs.
We chose to focus on γδ T cells and pan T cells, which also include CD8+ T cells. In this paper, we report that OCs are capable of expanding and functionally activating both γδ T cells and pan T cells. Expanded γδ T and pan T cells were capable of secreting high levels of INF-γ, albeit with different dynamics to those of NK cells, and, moreover, they are unable to kill NK-specific targets.
Since we used humanized-BLT (hu-BLT) mice as a model of human disease, we next determined whether NK and T cell activation through OCs is also evident in cells obtained from hu-BLT mice. Similar to humans, OCs were capable of increasing the cell expansion and secretion of IFN-γ in the culture of either NK or T cells from hu-BLT mice, providing yet further evidence that these mice are appropriate models to study human disease.
Therefore, these studies indicated that CD3+ T or γδ T cells can proliferate and be supercharged by OCs similar to the NK cells; thus, they can be used individually or in combination in the cell therapy of cancers.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。